So if you have a question, just get in touch Important notice Breastfeeding is best
(2023) 23:S21s120
As opposed to common treatment agents such as insulin and sulphonylureas, GLP-1-based treatment has been associated with weight loss and a lower risk of hypoglycemia, two important considerations for patients with type 2 diabetes
To assess this, randomized trials typically evaluate the primary outcome of major adverse cardiovascular events (MACE), which includes cardiovascular death, non-fatal stroke, and non-fatal myocardial infarction (MI)
Emptying the bladder regularly may help reduce bacterial build up and support urinary health
When compared to other GLP-1 medicationssuch as liraglutide (Saxenda), dulaglutide (Trulicity), and exenatide (Byetta)semaglutide generally leads to more pronounced and sustained weight loss outcomes